One GLP-1 in a peptide shop
The catalogue is repair and growth peptides, with semaglutide sitting among them as one card of eight. It is priced on the homepage and again on the weight-loss page, at the same figure both times, with no quiz in the way.
The description is clinical rather than promotional: a GLP-1 receptor agonist that regulates blood sugar and slows gastric emptying. That is the drug's mechanism, not a slimming claim.
Being able to read the GLP-1 figure against seven other peptides on the same grid is genuinely useful, and it is why the catalogue framing works in the reader's favour here.
A price that hides from a scanner
The figure is rendered across three separate elements, so a tool that reads each element on its own finds no price anywhere on this site.
Worse, once the page is flattened into plain text, each price ends up sitting immediately before the name of the next product. Read that way, the semaglutide card appears to cost what the copper-peptide card costs.
We resolved it inside each card's own markup instead, which puts the same figure on both pages and assigns the other two figures to the two products they belong to. It is worth spelling out because a research file working from flattened text would record a different price for this seller on each of its two pages.
The FAQ answers a different question
Asked what its weight-loss peptide therapy costs, the site answers with a range and adds that many insurance plans provide partial coverage.
The range is real — it spans the catalogue — but the GLP-1 sits at its very top, so a reader who takes the answer at face value will budget for the bottom of it.
Who is behind it
The operating company is named in the footer of every page and again in the terms and the privacy policy, both of which carry their own dates. The company's name and the brand's name have no word in common, which is precisely the case where somebody typing the company from memory gets it wrong.
No compounding pharmacy is named, no prescribing clinician is named, and no list of served states appears. The service is marketed to men.
We screened both the brand and the operating company against the FDA's live warning-letter table with both controls green and found nothing. That is a result about the table we searched.
VAULT Men's Health's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $399/moper month, printed inside the semaglutide card on both the homepage and the weight-loss page. ⛔ The figure renders across three separate text nodes, so a per-node price scan of this host returns nothing at all; and in the flattened text each figure sits NEXT TO THE FOLLOWING product name, so the pairing was resolved inside the card markup rather than by adjacency | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 264 providers reviewed here are paid partners today; the other 260 are not. See how this works.
See VAULT Men's Health's current price →Good fit if
- Men already buying peptides who want a GLP-1 priced beside them.
- Readers who want the drug's mechanism described in clinical terms.
- Buyers who want the operating company named on every page.
Look elsewhere if
- Anyone who wants a weight-loss programme rather than a catalogue line.
- Readers who need a compounding pharmacy or a prescriber named.
- Buyers who need their state confirmed.
- Women, and anyone wanting a brand-name option.
How this review was verified
- Read the homepage, the weight-loss page, the privacy policy and the terms on 7 September 2026, comparing requested to effective URLs, with a nonsense path on the same host in the same run, which returned a 404.
- Found the price invisible to a per-element scan and read it with an extractor that joins text nodes.
- Resolved which figure belongs to which product inside each product card's markup, after confirming that the flattened text pairs each figure with the following product and would have produced two different prices for this seller on its two pages.
- Read the cost FAQ in full and recorded that its answer is a catalogue-wide range rather than this drug's price.
- Screened the live FDA warning-letter table for both the brand and the operating company with a positive control returning exactly one row and a nonsense control returning none.